Status:
COMPLETED
Observational Study of the Value of Using Obstructive Sleep Apnea-hypopnea Syndrome (CPAP) Ventilation on the Occurrence of Respiratory and Cardiovascular Complications in Patients at High Risk of Obstructive Apnea Syndrome During Postoperative Sleep Surgery of a Major Abdominal Surgery.
Lead Sponsor:
Poitiers University Hospital
Conditions:
Major Abdominal Surgery
Eligibility:
All Genders
18-100 years
Brief Summary
The presence of an obstructive sleep apnea-hypopnea syndrome (OSAHS) is a perfectly identified cardiovascular and metabolic risk factor responsible for excess mortality in patients with severe OSAHS, ...
Eligibility Criteria
Inclusion
- Patients over 18 years old and naive to any treatment with obstructive sleep apnea-hypopnea syndrome,
- Patients at high risk of obstructive sleep apnea-hypopnea syndrome (STOP BANG ≥ 3),
- Patients scheduled for major abdominal surgery (all intraperitoneal surgeries excluding vesicles, eventrations and hernias, all aortic surgeries excluding endovascular surgeries) within a minimum of 10 days,
- It is possible to integrate the explanations concerning the realization of the ApneaLink ™ Air in autonomy and to ensure its restitution under 24-48h,
Exclusion
- Patients with obstructive sleep apnea-hypopnea syndrome diagnosed before surgery,
- Patients with heart failure (NYHA\> II),
- Patients with moderate to severe COPD
- Patients participating in a clinical trial,
Key Trial Info
Start Date :
June 14 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04345354
Start Date
June 14 2016
End Date
December 1 2018
Last Update
April 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu de Poitiers
Poitiers, France, 86021